Alpha Tau Medical Ltd (DRTS) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $7.93
• Market Cap: $717.92M
• EPS: $-0.59
• 52-Week High: $8.60
• 52-Week Low: $2.30

Market Sentiment

Alpha Tau Medical Ltd currently has a Bullish sentiment score of 0.73.

About Alpha Tau Medical Ltd

Alpha Tau Medical Ltd. (Ticker: DRTS) is a pioneering clinical-stage oncology company focused on the innovative development and commercialization of its proprietary alpha-emitting radiation therapy, Alpha DaRT, specifically designed to target solid tumors. Based in Jerusalem, Israel, with operational presence in the United States, the company is poised to transform cancer treatment by delivering a novel therapeutic approach that effectively reduces collateral damage to healthy tissue while en...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Alpha Tau Medical Ltd and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does DRTS pay dividends?

Alpha Tau Medical Ltd (DRTS) does not currently pay a regular dividend.

What is DRTS's market cap?

Alpha Tau Medical Ltd (DRTS) has a market capitalization of $717.92M with a current stock price of $7.93.